6
Clinical Trials associated with Moist exposed burn ointment (MEBO)A randomized controlled study of rehabilitation gauze versus MEBO in dressing change nursing after radical axillary osmidrotomy with small incision
Start Date19 Jan 2024 |
Sponsor / Collaborator- |
Assessing the Effects and Safety of MEBO as Add on Therapy for the Prevention of Radiotherapy-Induced Mucositis
Radiation therapy (RT) is used in at least 50% of cancer patients and is critical in treating and palliating tumor-related symptoms. Normal tissue radiation toxicity remains an overwhelming obstacle in treating cancer patients with localized tumors.
Mucositis is the inflammation and ulceration of the oral and gastrointestinal mucosa observed with different cancer therapies. Oral mucositis is a common, severe, and debilitating complication of RT occurring several days to weeks after RT initiation.
Assessment of Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer: Randomized Controlled Trial
This study aims to assess topical MEBO application on pain relief and wound healing.
100 Clinical Results associated with Moist exposed burn ointment (MEBO)
100 Translational Medicine associated with Moist exposed burn ointment (MEBO)
100 Patents (Medical) associated with Moist exposed burn ointment (MEBO)
100 Deals associated with Moist exposed burn ointment (MEBO)